Cargando…

Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death

BACKGROUND: Chronic graft-versus-host disease (cGVHD) is a serious complication of allogeneic hematopoietic cell transplantation (HCT). More accurate information regarding the risk of developing cGVHD is required. Bone marrow (BM) grafts contribute to lower cGVHD, which creates a dispute over whethe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Logan, Brent R., Fu, Denggang, Howard, Alan, Fei, Mingwei, Kou, Jianqun, Little, Morgan R., Adom, Djamilatou, Mohamed, Fathima A., Blazar, Bruce R., Gafken, Philip R., Paczesny, Sophie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2023
Materias:	Clinical Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378149/ https://www.ncbi.nlm.nih.gov/pubmed/37526081 http://dx.doi.org/10.1172/JCI168575

Ejemplares similares

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
por: Jiang, Hua, et al.
Publicado: (2021)

Granzyme A–producing T helper cells are critical for acute graft-versus-host disease
por: Park, Sungtae, et al.
Publicado: (2020)

Biomarkers for Allogeneic HCT Outcomes
por: Adom, Djamilatou, et al.
Publicado: (2020)

Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease
por: Thangavelu, Govindarajan, et al.
Publicado: (2019)

Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease
por: Mohamed, Fathima A., et al.
Publicado: (2021)

Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges
por: Hefazi, Mehrdad, et al.
Publicado: (2021)

Mechanisms by Which Obesity Promotes Acute Graft-Versus-Host Disease in Mice
por: Khuat, Lam T., et al.
Publicado: (2021)

Specifically differentiated T cell subset promotes tumor immunity over fatal immunity
por: Ramadan, Abdulraouf, et al.
Publicado: (2017)

Emerging translational strategies and challenges for enhancing regulatory T cell therapy for graft-versus-host disease
por: Hippen, Keli L., et al.
Publicado: (2022)

Validation of Minnesota acute graft-versus-host disease Risk Score
por: MacMillan, Margaret L., et al.
Publicado: (2020)

Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease
por: Le, Hongnga T., et al.
Publicado: (2020)

Targeting the Retinoid X Receptor Pathway Prevents and Ameliorates Murine Chronic Graft-Versus-Host Disease
por: Thangavelu, Govindarajan, et al.
Publicado: (2022)

Murine CAR19 Tregs suppress acute graft-versus-host disease and maintain graft-versus-tumor responses
por: Bolivar-Wagers, Sara, et al.
Publicado: (2022)

Cytolytic CD4(+) and CD8(+) Regulatory T-Cells and Implications for Developing Immunotherapies to Combat Graft-Versus-Host Disease
por: Bolivar-Wagers, Sara, et al.
Publicado: (2022)

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
por: Fiema, Bryan, et al.
Publicado: (2012)

Effects of MicroRNA on Regulatory T Cells and Implications for Adoptive Cellular Therapy to Ameliorate Graft-versus-Host Disease
por: Hippen, Keli L., et al.
Publicado: (2018)

Regenerating islet-derived protein 3-α is a prognostic biomarker for gastrointestinal chronic graft-versus-host disease
por: DePriest, Brittany Paige, et al.
Publicado: (2022)

High cutaneous amphiregulin expression predicts fatal acute graft‐versus‐host disease
por: Schultz, Brittney, et al.
Publicado: (2022)

Higher Therapeutic Cyclosporine Levels Early Post-Transplantation Reduces Risks of Acute Graft-Versus-Host Disease and Improves Survival
por: Rogosheske, John R., et al.
Publicado: (2013)

Analyses and Correlation of Pathologic and Ocular Cutaneous Changes in Murine Graft versus Host Disease
por: Levy, Robert B., et al.
Publicado: (2021)

A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft‐versus‐host disease
por: Pratta, Michael, et al.
Publicado: (2022)

Deletion of AMPK minimizes graft-versus-host disease through an early impact on effector donor T cells
por: Monlish, Darlene A., et al.
Publicado: (2021)

IL-33 acts as a costimulatory signal to generate alloreactive Th1 cells in graft-versus-host disease
por: Dwyer, Gaelen K., et al.
Publicado: (2022)

ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease
por: Jagasia, Madan, et al.
Publicado: (2021)

Bone grafts in dentistry
por: Kumar, Prasanna, et al.
Publicado: (2013)

Donor and Recipient Plasma Follistatin Levels are Associated with Acute Graft-versus-Host Disease in Blood and Marrow Transplant Clinical Trials Network 0402
por: Turcotte, Lucie M., et al.
Publicado: (2017)

Graft-versus-host disease may cause pulmonary restriction, but not all restriction is graft-versus-host disease
por: Sheshadri, Ajay, et al.
Publicado: (2022)

GRAFT-VS.-HOST REACTION IN TISSUE CULTURE
por: Auerbach, Robert, et al.
Publicado: (1973)

Recent advances in graft-versus-host disease
por: Flinn, Aisling M, et al.
Publicado: (2023)

Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated
por: Nikiforow, Sarah, et al.
Publicado: (2018)

Graft-Versus-Host Disease: A Surge of Developments
por: Riddell, Stanley R, et al.
Publicado: (2007)

Graft-Versus-Host Disease–Free Antitumoral Signature After Allogeneic Donor Lymphocyte Injection Identified by Proteomics and Systems Biology
por: Liu, Xiaowen, et al.
Publicado: (2019)

Graft-versus-host disease after liver transplantation
por: Chaib, Eleazar, et al.
Publicado: (2011)

Osteostimulatory effect of bone grafts on fibroblast cultures
por: Fathima, Hameed, et al.
Publicado: (2015)

After Bone Marrow Transplantation, the Cell-Intrinsic Th2 Pathway Promotes Recipient T Lymphocyte Survival and Regulates Graft-versus-Host Disease
por: Truscott, Jamie, et al.
Publicado: (2023)

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report
por: Kitko, Carrie L., et al.
Publicado: (2021)

Repeat corneal graft failure due to graft-to-host herpetic infection
por: Gatzioufas, Zisis, et al.
Publicado: (2013)

Isomorphic Sclerotic-Type Cutaneous Chronic Graft-Versus-Host Disease: Report and Review of Chronic Graft-Versus-Host Disease in a Cutaneous Immunocompromised District
por: Cohen, Philip R.
Publicado: (2013)

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study
por: Cutler, Corey, et al.
Publicado: (2021)

GRAFT-VS.-HOST REACTIONS IN RECIPROCAL HYBRID MICE : I. DISSOCIATION OF T-CELL ACTIVITIES IN THE MIXED LYMPHOCYTE REACTION AND TWO GRAFT-VS.-HOST ASSAYS
por: Morse, Herbert C., et al.
Publicado: (1974)

Cannot write session to /tmp/vufind_sessions/sess_hl77ogpgartkhq7adafkignlfo